1. Home
  2. EBON vs BFRI Comparison

EBON vs BFRI Comparison

Compare EBON & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$2.16

Market Cap

16.0M

Sector

Technology

ML Signal

N/A

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.06

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
BFRI
Founded
2010
1997
Country
China
United States
Employees
N/A
94
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
13.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
EBON
BFRI
Price
$2.16
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
12.5K
381.2K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$0.57
52 Week High
$5.90
$1.21

Technical Indicators

Market Signals
Indicator
EBON
BFRI
Relative Strength Index (RSI) 45.22 52.43
Support Level $1.74 $0.77
Resistance Level $2.76 $1.14
Average True Range (ATR) 0.23 0.09
MACD -0.01 -0.00
Stochastic Oscillator 44.12 48.73

Price Performance

Historical Comparison
EBON
BFRI

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: